BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19067737)

  • 1. Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells.
    Minke KS; Staib P; Puetter A; Gehrke I; Gandhirajan RK; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
    Eur J Haematol; 2009 Mar; 82(3):165-75. PubMed ID: 19067737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4.
    Tickenbrock L; Hehn S; Sargin B; Choudhary C; Bäumer N; Buerger H; Schulte B; Müller O; Berdel WE; Müller-Tidow C; Serve H
    Int J Oncol; 2008 Dec; 33(6):1215-21. PubMed ID: 19020754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
    Gozzini A; Rovida E; Dello Sbarba P; Galimberti S; Santini V
    Cancer Res; 2003 Dec; 63(24):8955-61. PubMed ID: 14695213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibitors of Wnt/beta-catenin/lef-1 signaling induces apoptosis in chronic lymphocytic leukemia cells in vitro and in vivo.
    Gandhirajan RK; Staib PA; Minke K; Gehrke I; Plickert G; Schlösser A; Schmitt EK; Hallek M; Kreuzer KA
    Neoplasia; 2010 Apr; 12(4):326-35. PubMed ID: 20360943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms.
    Park S; Han SS; Park CH; Hahm ER; Lee SJ; Park HK; Lee SH; Kim WS; Jung CW; Park K; Riordan HD; Kimler BF; Kim K; Lee JH
    Int J Biochem Cell Biol; 2004 Nov; 36(11):2180-95. PubMed ID: 15313465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
    Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
    Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
    Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
    Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
    Muranyi AL; Dedhar S; Hogge DE
    Exp Hematol; 2009 Apr; 37(4):450-60. PubMed ID: 19302919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of beta-catenin and topoisomerase IIalpha in de novo acute myeloid leukemia.
    Chen CC; Gau JP; You JY; Lee KD; Yu YB; Lu CH; Lin JT; Lan C; Lo WH; Liu JM; Yang CF
    Am J Hematol; 2009 Feb; 84(2):87-92. PubMed ID: 19127593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional mutations of beta-catenin and APC reveal roles for canonical Wnt signaling in lens differentiation.
    Martinez G; Wijesinghe M; Turner K; Abud HE; Taketo MM; Noda T; Robinson ML; de Iongh RU
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4794-806. PubMed ID: 19515997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia.
    Valencia A; Román-Gómez J; Cervera J; Such E; Barragán E; Bolufer P; Moscardó F; Sanz GF; Sanz MA
    Leukemia; 2009 Sep; 23(9):1658-66. PubMed ID: 19387464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt signaling inhibits cementoblast differentiation and promotes proliferation.
    Nemoto E; Koshikawa Y; Kanaya S; Tsuchiya M; Tamura M; Somerman MJ; Shimauchi H
    Bone; 2009 May; 44(5):805-12. PubMed ID: 19442631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of mTOR is associated with decreased growth and decreased VEGF expression in acute myeloid leukaemia cells.
    Böhm A; Aichberger KJ; Mayerhofer M; Herrmann H; Florian S; Krauth MT; Derdak S; Samorapoompichit P; Sonneck K; Vales A; Gleixner KV; Pickl WF; Sperr WR; Valent P
    Eur J Clin Invest; 2009 May; 39(5):395-405. PubMed ID: 19320940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells.
    Song G; Liao X; Zhou L; Wu L; Feng Y; Han ZC
    Leuk Res; 2004 Oct; 28(10):1089-96. PubMed ID: 15289023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proliferation and bone marrow engraftment of AML blasts is dependent on β-catenin signalling.
    Siapati EK; Papadaki M; Kozaou Z; Rouka E; Michali E; Savvidou I; Gogos D; Kyriakou D; Anagnostopoulos NI; Vassilopoulos G
    Br J Haematol; 2011 Jan; 152(2):164-74. PubMed ID: 21118196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic inactivation of secreted Frizzled-related proteins in acute myeloid leukaemia.
    Jost E; Schmid J; Wilop S; Schubert C; Suzuki H; Herman JG; Osieka R; Galm O
    Br J Haematol; 2008 Sep; 142(5):745-53. PubMed ID: 18537968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of beta-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis.
    Ysebaert L; Chicanne G; Demur C; De Toni F; Prade-Houdellier N; Ruidavets JB; Mansat-De Mas V; Rigal-Huguet F; Laurent G; Payrastre B; Manenti S; Racaud-Sultan C
    Leukemia; 2006 Jul; 20(7):1211-6. PubMed ID: 16688229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.